Status:
UNKNOWN
Zonulin Biomarker for Diagnosis of Hip and Knee Infections
Lead Sponsor:
Rothman Institute Orthopaedics
Conditions:
Surgical Site Infection
Zonulin
Eligibility:
All Genders
18+ years
Brief Summary
Prior studies investigating the etiopathogenesis of surgical site infection (SSI) traditionally suggested three main ways for the infection to occur: local contamination occurring during the surgery, ...
Eligibility Criteria
Inclusion
- Patients who underwent primary or aseptic revision total hip and knee arthroplasty.
- Patients who underwent revision total hip and knee arthroplasty for infective reasons
- Patients 18 years of age or older
Exclusion
- \- Patients younger than 18 years old
Key Trial Info
Start Date :
November 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04666519
Start Date
November 15 2020
End Date
December 31 2021
Last Update
December 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, United States, 19107